Otogenic CSVT Retrospective Case Series and Associated Thrombophilia
CSVT PCR
Otogenic Cerebral Sinus Vein Thrombosis in Children: Retrospective Case Series and Associated Thrombophilia
1 other identifier
observational
9
1 country
1
Brief Summary
The aim of this study is to report the clinical presentation, Microbiological, laboratory and imaging evaluation, prothrombotic factors analysis, medical and surgical management and outcomes in children with Otogenic Cerebral Sinus Vein Thrombosis (CSVT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2019
CompletedFirst Submitted
Initial submission to the registry
February 23, 2019
CompletedFirst Posted
Study publicly available on registry
March 6, 2019
CompletedMarch 6, 2019
March 1, 2019
2 months
February 23, 2019
March 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Clinical Presentation
Clinical presentation signs and symptoms will be collected and a summary will be represented in a table including all subjects
All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
Cultures result
the results of cultures from blood, ear secretions, surgery samples, and PCR(polymerize chain reaction assay) will be summarized for the percentage of each pathogen and number of positive results from each type of test
All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
Morbidity and Mortality
The percentage of Morbidity and Mortality until the end of the follow-up period. Morbidity will include any long term sequelae including permanent neurological deficits, chronic ear inflammation, recurrent mastoiditis, and recurrent thromboembolic events.
All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
Surgical intervention
Summary of all surgical interventions, and determination of the common types of surgery performed.
All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
Thrombophilia evaluation tests
Thrombophilia evaluation test results will be collected and a summary will be represented in a table including all subjects
All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
Secondary Outcomes (1)
Imaging Studies results
All cases and follow up documentation reported up to a designated date 31 August 2018 predetermined by the institutional ethics committee
Study Arms (1)
Pediatric Otogenic CSVT
Children with Otogenic Cerebral Sinus Vein Thrombosis (CSVT)
Eligibility Criteria
Children with otogenic CSVT
You may qualify if:
- age of 18 years or younger
- both sexes are included
- a clinical or radiological finding of mastoiditis in the patient's file
- Documentation of CSVT in an imaging study, either CT or MRI.
You may not qualify if:
- age above 18 years
- lack of a clinical or radiological finding of mastoiditis in the patient's file
- Lack of documentation of CSVT in an imaging study, either CT or MRI.
- previous unprovoked venous thromboembolism event.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HaEmek Medical Center
Afula, 1834111, Israel
Related Publications (11)
Ichord R. Cerebral Sinovenous Thrombosis. Front Pediatr. 2017 Jul 27;5:163. doi: 10.3389/fped.2017.00163. eCollection 2017.
PMID: 28798906BACKGROUNDSkinner R, Koller K, McIntosh N, McCarthy A, Pizer B; United Kingdom Children's Cancer Study Group (UKCCSG); Paediatric Oncology Nursing Forum (PONF) Supportive Care Group. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. Pediatr Blood Cancer. 2008 Apr;50(4):826-30. doi: 10.1002/pbc.21332.
PMID: 17729250BACKGROUNDSchneider S, Kapelushnik J, Kraus M, El Saied S, Levi I, Kaplan DM. The association between otogenic lateral sinus thrombosis and thrombophilia - A long-term follow-up. Am J Otolaryngol. 2018 May-Jun;39(3):299-302. doi: 10.1016/j.amjoto.2018.03.013. Epub 2018 Mar 7.
PMID: 29530427BACKGROUNDKenet G, Waldman D, Lubetsky A, Kornbrut N, Khalil A, Koren A, Wolach B, Fattal A, Kapelushnik J, Tamary H, Yacobovitch J, Raveh E, Revel-Vilk S, Toren A, Brenner B. Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. Thromb Haemost. 2004 Oct;92(4):713-8. doi: 10.1160/TH04-03-0182.
PMID: 15467900BACKGROUNDZanoletti E, Cazzador D, Faccioli C, Sari M, Bovo R, Martini A. Intracranial venous sinus thrombosis as a complication of otitis media in children: Critical review of diagnosis and management. Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2398-403. doi: 10.1016/j.ijporl.2015.10.059. Epub 2015 Nov 5.
PMID: 26590005BACKGROUNDNovoa E, Podvinec M, Angst R, Gurtler N. Paediatric otogenic lateral sinus thrombosis: therapeutic management, outcome and thrombophilic evaluation. Int J Pediatr Otorhinolaryngol. 2013 Jun;77(6):996-1001. doi: 10.1016/j.ijporl.2013.03.030. Epub 2013 Apr 29.
PMID: 23639339BACKGROUNDKenet G, Kirkham F, Niederstadt T, Heinecke A, Saunders D, Stoll M, Brenner B, Bidlingmaier C, Heller C, Knofler R, Schobess R, Zieger B, Sebire G, Nowak-Gottl U; European Thromboses Study Group. Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 2007 Jul;6(7):595-603. doi: 10.1016/S1474-4422(07)70131-X.
PMID: 17560171BACKGROUNDKvaerner KJ, Bentdal Y, Karevold G. Acute mastoiditis in Norway: no evidence for an increase. Int J Pediatr Otorhinolaryngol. 2007 Oct;71(10):1579-83. doi: 10.1016/j.ijporl.2007.06.022. Epub 2007 Aug 20.
PMID: 17707917BACKGROUNDdeVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, MacDonald EA, Gillett J, Meaney B, Shevell M, Sinclair DB, Yager J; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001 Aug 9;345(6):417-23. doi: 10.1056/NEJM200108093450604.
PMID: 11496852BACKGROUNDPang LH, Barakate MS, Havas TE. Mastoiditis in a paediatric population: a review of 11 years experience in management. Int J Pediatr Otorhinolaryngol. 2009 Nov;73(11):1520-4. doi: 10.1016/j.ijporl.2009.07.003. Epub 2009 Sep 15.
PMID: 19758711BACKGROUNDPalma S, Fiumana E, Borgonzoni M, Bovo R, Rosignoli M, Martini A. Acute mastoiditis in children: the "Ferrara" experience. Int J Pediatr Otorhinolaryngol. 2007 Nov;71(11):1663-9. doi: 10.1016/j.ijporl.2007.06.018. Epub 2007 Aug 2.
PMID: 17681615BACKGROUND
Biospecimen
cultures from blood, ear secretions and samples collected during a surgical procedure. also PCR (polymerase chain reaction assay) analysis for bacterial RNA.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kfir Siag, MD
haemek medical center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Siag Kfir
Study Record Dates
First Submitted
February 23, 2019
First Posted
March 6, 2019
Study Start
December 2, 2018
Primary Completion
February 3, 2019
Study Completion
February 3, 2019
Last Updated
March 6, 2019
Record last verified: 2019-03